Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SciClone, Sigma-Tau Updates On Zadaxin Trial
According to investigators, Zadaxin treatment given with the H1N1 vaccine led to an (p value=0.04) increase in the percentage of subjects who seroconverted, also when evaluated 42 days
According to investigators, Zadaxin treatment given with the H1N1 vaccine led to an (p value=0.04) increase in the percentage of subjects who seroconverted, also when evaluated 42 days
Nephoxil (ferric citrate) is a differentiated, iron-based phosphate binder for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end stage renal disease (ESRD). Nephoxil is free
The new patent is based on the research by Alnylam scientists on systemic delivery of RNAi therapeutics as documented in Soutschek et al (Nature 432, 173-178 (11 November
CPI-300 is a new, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL(R). IntelGenx’s development partner, Cary Pharma, serves as the NDA applicant for CPI-300. The
As per the agreement, AnaptysBio is likely to be responsible for generating new antibodies to a specified disease target, using its proprietary somatic hypermutation (SHM) technology platform. Merck
Tramadol/APAP is a centrally-acting analgesic indicated for the short-term management of moderately severe acute pain. The product is designated as a controlled substance in some states. Amneal began
Reportedly, results from a study suggested that variation in PI3K gene can work as a useful biomarker, as a companion diagnostic with several other cancer treatment. The study
In the study, neither change in particle characteristics such as size or charge nor loss in siRNA integrity was observed. The company’s proprietary UsiRNA constructs in the DiLA2
The BD Microtainer MAP is a microtube to be compatible with automated hematology instruments, reducing turnaround time and costs associated with sample transfer and relabeling. The BD Microtainer
Reportedly, the study enrolled 241 subjects, including 221 who were randomised to receive either VLP vaccine at 15mcg or 60mcg doses or a placebo and 20 subjects who